Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 41Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Myelodysplastic Syndromes 31Leukemia, Myelogenous, Chronic, BCR-ABL Positive 21Hodgkin Disease 18Hematologic Neoplasms 18Lymphoma, Non-Hodgkin 16Myeloproliferative Disorders 14Leukemia, Lymphocytic, Chronic, B-Cell 13Leukemia, Biphenotypic, Acute 13Leukemia 13Graft vs Host Disease 13Leukemia, Myelomonocytic, Chronic 12Lymphoma 11Anemia, Refractory, with Excess of Blasts 11Multiple Myeloma 10Primary Myelofibrosis 9Lymphoma, Mantle-Cell 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 6Leukemia, Prolymphocytic 6Waldenstrom Macroglobulinemia 5Lymphoma, Large B-Cell, Diffuse 5Hematologic Diseases 5Burkitt Lymphoma 5Anemia, Aplastic 5Polycythemia Vera 4Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Myeloid 4Blast Crisis 4

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Mycophenolic Acid 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-Malignant Neoplasm × Mycophenolic Acid × 1 year × Clear all
NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
40 enrolled
Other neoplasm

Non-Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡